Paul Mesburis

Paul Mesburis

Director/Board Member at AVIVAGEN INC.
56 year
Health Technology
Finance
Consumer Services

Profile

Paul Mesburis is Lead Independent Director at Avivagen, Inc. since 2016.
Director at Access Energy (Asia) Pte Ltd. and Access Energy Co. Ltd. since 2015.
Member of the Institute of Corporate Directors.
Chief Financial Officer at Psygen Industries Ltd. since 2021.
Former Co-Chairman of FuelPositive Corp.
from 2016 to 2019.
Independent Non-Executive Director at Liminal BioSciences, Inc. from 2009 to 2019.
Independent Director at EEStor, Inc. from 2014 to 2016.
Independent Director at Galactic Gold Corp.
from 2019 to 2021.
Vice President at Mavrix Fund Management, Inc. from 2005 to 2009.
CCO & Senior Portfolio Manager at Excel Investment Counsel, Inc. Education includes undergraduate studies at the University of Toronto and an MBA from The Schulich School of Business.

Paul Mesburis active positions

CompaniesPositionStart
AVIVAGEN INC. Director/Board Member 05/04/2016
Access Energy (Asia) Pte Ltd.
Director/Board Member 01/01/2015
Access Energy Co. Ltd.
Director/Board Member 01/01/2015
Corporate Officer/Principal -
Director of Finance/CFO 01/01/2021

Former positions of Paul Mesburis

CompaniesPositionEnd
GALACTIC GOLD CORP. Director/Board Member 25/03/2021
LIMINAL BIOSCIENCES INC. Director/Board Member 19/06/2019
FUELPOSITIVE CORPORATION Chairman 30/04/2019
Director/Board Member 01/01/2016
░░░░░░ ░░░░ ░░░░░░░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░░░░░░░
See the detail of Paul Mesburis's experience

Training of Paul Mesburis

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

Connections

47

1st degree connections

13

1st degree companies

Male

Female

Members of the board

Executives

Linked companies

Private companies13

Health Technology

Producer Manufacturing

Finance

Consumer Services

Commercial Services

Health Technology

Commercial Services

Finance

Consumer Services

Access Energy (Asia) Pte Ltd.

Access Energy Co. Ltd.

Non-Energy Minerals

Health Technology